US Stock MarketDetailed Quotes

RNA Avidity Biosciences

Watchlist
  • 32.490
  • -1.270-3.76%
Close Dec 13 16:00 ET
  • 32.000
  • -0.490-1.51%
Post 17:47 ET
3.88BMarket Cap-11.28P/E (TTM)

Avidity Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-17.10%2.34M
-11.70%2.05M
58.67%3.54M
3.64%9.56M
-20.80%2.19M
13.54%2.82M
6.34%2.32M
24.40%2.23M
-1.09%9.22M
49.51%2.77M
Operating revenue
-17.10%2.34M
-11.70%2.05M
58.67%3.54M
3.64%9.56M
-20.80%2.19M
13.54%2.82M
6.34%2.32M
24.40%2.23M
-1.09%9.22M
49.51%2.77M
Cost of revenue
Gross profit
Operating expense
63.52%100.47M
54.09%84.67M
34.93%80.73M
30.31%245.16M
23.11%68.94M
29.60%61.44M
13.35%54.95M
65.02%59.83M
47.70%188.14M
38.60%55.99M
Selling and administrative expenses
69.52%23.27M
68.85%20.73M
15.20%13.9M
43.61%54.19M
55.23%16.12M
36.01%13.73M
41.32%12.28M
40.82%12.06M
44.05%37.73M
39.74%10.38M
-General and administrative expense
69.52%23.27M
68.85%20.73M
15.20%13.9M
43.61%54.19M
55.23%16.12M
36.01%13.73M
41.32%12.28M
40.82%12.06M
44.05%37.73M
39.74%10.38M
Research and development costs
61.79%77.2M
49.84%63.94M
39.92%66.83M
26.97%190.97M
15.80%52.82M
27.86%47.71M
7.25%42.67M
72.51%47.77M
48.65%150.4M
38.35%45.61M
Operating profit
-67.39%-98.13M
-56.98%-82.63M
-34.01%-77.19M
-31.68%-235.6M
-25.40%-66.74M
-30.48%-58.63M
-13.68%-52.63M
-67.14%-57.6M
-51.56%-178.91M
-38.08%-53.23M
Net non-operating interest income expense
186.11%17.97M
107.05%11.95M
52.88%8.43M
381.85%23.97M
131.06%6.41M
367.96%6.28M
844.52%5.77M
2,106.40%5.52M
4,683.65%4.98M
4,940.00%2.77M
Non-operating interest income
186.11%17.97M
107.05%11.95M
52.88%8.43M
381.85%23.97M
131.06%6.41M
367.96%6.28M
844.52%5.77M
2,106.40%5.52M
4,683.65%4.98M
4,940.00%2.77M
Other net income (expense)
-1,684.62%-232K
28.40%-116K
67.83%-101K
-942.11%-594K
-483.33%-105K
-8.33%-13K
-8,000.00%-162K
-1,156.00%-314K
8.06%-57K
60.87%-18K
Other non- operating income (expenses)
-1,684.62%-232K
28.40%-116K
67.83%-101K
-942.11%-594K
-483.33%-105K
-8.33%-13K
-8,000.00%-162K
-1,156.00%-314K
8.06%-57K
60.87%-18K
Income before tax
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Income tax
Net income
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Net income continuous Operations
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Minority interest income
Net income attributable to the parent company
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Basic earnings per share
8.45%-0.65
1.52%-0.65
-6.76%-0.79
12.87%-2.91
9.09%-0.8
13.41%-0.71
28.26%-0.66
-4.23%-0.74
-17.19%-3.34
46.34%-0.88
Diluted earnings per share
8.45%-0.65
1.52%-0.65
-6.76%-0.79
12.87%-2.91
9.09%-0.8
13.41%-0.71
28.26%-0.66
-4.23%-0.74
-17.19%-3.34
46.34%-0.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -17.10%2.34M-11.70%2.05M58.67%3.54M3.64%9.56M-20.80%2.19M13.54%2.82M6.34%2.32M24.40%2.23M-1.09%9.22M49.51%2.77M
Operating revenue -17.10%2.34M-11.70%2.05M58.67%3.54M3.64%9.56M-20.80%2.19M13.54%2.82M6.34%2.32M24.40%2.23M-1.09%9.22M49.51%2.77M
Cost of revenue
Gross profit
Operating expense 63.52%100.47M54.09%84.67M34.93%80.73M30.31%245.16M23.11%68.94M29.60%61.44M13.35%54.95M65.02%59.83M47.70%188.14M38.60%55.99M
Selling and administrative expenses 69.52%23.27M68.85%20.73M15.20%13.9M43.61%54.19M55.23%16.12M36.01%13.73M41.32%12.28M40.82%12.06M44.05%37.73M39.74%10.38M
-General and administrative expense 69.52%23.27M68.85%20.73M15.20%13.9M43.61%54.19M55.23%16.12M36.01%13.73M41.32%12.28M40.82%12.06M44.05%37.73M39.74%10.38M
Research and development costs 61.79%77.2M49.84%63.94M39.92%66.83M26.97%190.97M15.80%52.82M27.86%47.71M7.25%42.67M72.51%47.77M48.65%150.4M38.35%45.61M
Operating profit -67.39%-98.13M-56.98%-82.63M-34.01%-77.19M-31.68%-235.6M-25.40%-66.74M-30.48%-58.63M-13.68%-52.63M-67.14%-57.6M-51.56%-178.91M-38.08%-53.23M
Net non-operating interest income expense 186.11%17.97M107.05%11.95M52.88%8.43M381.85%23.97M131.06%6.41M367.96%6.28M844.52%5.77M2,106.40%5.52M4,683.65%4.98M4,940.00%2.77M
Non-operating interest income 186.11%17.97M107.05%11.95M52.88%8.43M381.85%23.97M131.06%6.41M367.96%6.28M844.52%5.77M2,106.40%5.52M4,683.65%4.98M4,940.00%2.77M
Other net income (expense) -1,684.62%-232K28.40%-116K67.83%-101K-942.11%-594K-483.33%-105K-8.33%-13K-8,000.00%-162K-1,156.00%-314K8.06%-57K60.87%-18K
Other non- operating income (expenses) -1,684.62%-232K28.40%-116K67.83%-101K-942.11%-594K-483.33%-105K-8.33%-13K-8,000.00%-162K-1,156.00%-314K8.06%-57K60.87%-18K
Income before tax -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Income tax
Net income -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Net income continuous Operations -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Minority interest income
Net income attributable to the parent company -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Basic earnings per share 8.45%-0.651.52%-0.65-6.76%-0.7912.87%-2.919.09%-0.813.41%-0.7128.26%-0.66-4.23%-0.74-17.19%-3.3446.34%-0.88
Diluted earnings per share 8.45%-0.651.52%-0.65-6.76%-0.7912.87%-2.919.09%-0.813.41%-0.7128.26%-0.66-4.23%-0.74-17.19%-3.3446.34%-0.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List